CSL Finance Limited Revenue and Competitors

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • CSL Finance Limited's estimated annual revenue is currently $28.9M per year.(i)
  • CSL Finance Limited's estimated revenue per employee is $115,500

Employee Data

  • CSL Finance Limited has 250 Employees.(i)
  • CSL Finance Limited grew their employee count by 7% last year.

CSL Finance Limited's People

NameTitleEmail/Phone
1
AVP - IT Business Application & SupportReveal Email/Phone
2
Assistant Manager Human ResourcesReveal Email/Phone
3
Sr. Manager - HRReveal Email/Phone
4
Sr. Manager Information TechnologyReveal Email/Phone
5
Executive assistant cum HRReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$144.1M98011%N/AN/A
#2
$150.1M102112%N/AN/A
#3
$321M218426%N/AN/A
#4
$44.6M34028%N/AN/A
#5
$201.8M1373-2%N/AN/A
#6
$19.3M167-8%N/AN/A
#7
$288.4M196211%N/AN/A
#8
$18.2M1585%N/AN/A
#9
$113.9M77510%N/AN/A
#10
$49M37312%N/AN/A
Add Company

What Is CSL Finance Limited?

CSL Finance Limited was incorporated on 28th December 1992. We are a Non-Banking Finance Company registered with the Reserve Bank of India and listed on the Bombay Stock Exchange. The company provides secured loans and bridge finance to mid sized corporates and has recently forayed into SME Loan segment. It aims to fulfill the financial needs of small and medium enterprises through a suite of secured and unsecured loan products. CSL is run by a committed team of professionals with years of rich experience in Corporate and SME Lending.

keywords:N/A

N/A

Total Funding

250

Number of Employees

$28.9M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CSL Finance Limited News

2022-04-17 - CSL share price lifts amid US$4b debt raise

The CSL Limited (ASX: CSL) share price is edging higher in early trading ... The notes were issued by CSL Finance and are guaranteed by the...

2022-03-22 - European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B

... and serious medical disorders," said Bill Mezzanotte, Executive Vice President, Head of R&D and Chief Medical Officer for CSL Limited.

2019-09-08 - Do Insiders Own Shares In Comstock Metals Ltd. (CVE:CSL)?

A look at the shareholders of Comstock Metals Ltd. (CVE:CSL) can tell us which group is most powerful. Insiders often own a large chunk of ...

2019-09-03 - CSL Limited (ASX:CSL): Is It A Good Long Term Opportunity?

In August 2019, CSL Limited (ASX:CSL) released its latest earnings announcement, ... Financial Health: Does it have a healthy balance sheet?

2019-09-03 - Should you buy CSL and these ASX healthcare shares?

CSL Limited (ASX: CSL). CSL continues to be my favourite healthcare share. I think the biotherapeutics giant is one of the best buy and hold ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.1M250116%N/A
#2
$40M251-6%N/A
#3
$20.9M2628%N/A
#4
$26M263-52%N/A
#5
$26M2635%N/A